This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Monsanto Grows Controversy on Genetically Modified Food


Both Monsanto and DuPont produce and market corn and soybeans that have been genetically engineered to withstand weed killers, while producing an insecticidal protein to fight pests without the need for additional chemical sprays.

The key areas of controversy related to genetically modified food are:

  • whether detailed labeling should be required by law;
  • what is the role and expanse of government regulators and at what level;
  • what are the effects of genetically modified crops on health and the environment;
  • what is the effect on pesticide resistance
  • is the impact of genetically modified crops positive or negative for farmers; and
  • what should be the role of genetically modified crops in meeting the needs of a rapidly growing global populace, particularly in emerging market nations where the health and food safety laws are not as stringent as in the United States.

At present, the U.S. Food and Drug Administration supports voluntary labeling by food manufacturers.

Greenpeace, the Organic Consumers Association and others support labeling efforts due to their contention that current regulatory efforts are anemic and the food derived from genetically modified organisms may be unsafe, threatening other sources.

While labeling efforts may seem benign, there would be a greatly increased legal liability for companies in the industry if the efforts prevail. It would also facilitate greater regulatory expansion for the other aspects of the role of bioengineering and chemicals in the food sector.

Opponents of more laws and regulations on the industry point out that esteemed scientific institutions such as the British Royal Society, the World Health Organization, the American Association for the Advancement of Science and others have determined that genetically modified foods on the market are no riskier than conventional foods.

Greater amounts on lobbying should be expected from Monsanto, DuPont, Dow Chemical and others in the future. Monsanto recently hired the former chair of the Senate Agriculture Committee, Blanche Lincoln, as a lobbyist. For the former senator and others employed by Monsanto, DuPont and others, making the Farmer Assurance Provision permanent will obviously be a priority in the next Congress. At the state level, there will be more efforts, some repeats.

What will be new, however, is the higher and higher amounts expended by Monsanto and other to defeat food labeling attempts at all levels of government.

At the time of publication the author had no position in any of the stocks mentioned.

This article was written by an independent contributor, separate from TheStreet's regular news coverage.

Jonathan Yates does not have a position in any of the stocks mentioned in this article.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs